Reference |
---|
Harmon J, Spengler J, Coleman McCray J, Nichol S, Spiropoulou C, McElroy A. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis. J Virol. 2018;92: pubmed publisher
|
Suschak J, BAGLEY K, Shoemaker C, Six C, Kwilas S, Dupuy L, et al. The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice. J Infect Dis. 2018;218:S519-S527 pubmed publisher
|
Zheng D, Chen S, Qu D, Chen J, Wang F, Zhang R, et al. Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses. Vaccine. 2016;34:6464-6471 pubmed publisher
|
Matheoud D, Sugiura A, Bellemare Pelletier A, Laplante A, Rondeau C, Chemali M, et al. Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell. 2016;166:314-327 pubmed publisher
|
Mazor R, Crown D, Addissie S, Jang Y, Kaplan G, Pastan I. Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo. Cell Mol Immunol. 2017;14:432-442 pubmed publisher
|
Holmström F, Pasetto A, Nähr V, Brass A, Kriegs M, Hildt E, et al. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice. J Immunol. 2013;190:1113-24 pubmed publisher
|
Johannsen A, Genolet R, Legler D, Luther S, Luescher I. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice. J Immunol. 2010;185:3445-55 pubmed publisher
|